Assessing the cost-effectiveness of HAART for adults with HIV in England (Q57181353)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737376%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Assessing the cost-effectiveness of HAART for adults with HIV in England (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737376%20AND%20SRC:MED&resulttype=core&format=json

cost-effectiveness analysis

4 December 2019

main subject

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737376%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

5

A Mocroft

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737376%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

P Trueman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737376%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M Youle

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737376%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M Johnson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737376%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A H Miners

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737376%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

E J Beck

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737376%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737376%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737376%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737376%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737376%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

52-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737376%20AND%20SRC:MED&resulttype=core&format=json

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

The Markov process in medical prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

Statistical analysis of the stages of HIV infection using a Markov model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

An introduction to Markov modelling for economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

Markov models in medical decision making: a practical guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

Modelling the Cost Effectiveness of Lamivudine/Zidovudine Combination Therapy in HIV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

The cost-effectiveness of triple nucleoside analogue therapy antiretroviral regimens in the treatment of HIV in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

Virological response to protease inhibitor therapy in an HIV clinic cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

Multi-attribute preference functions. Health Utilities Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

Measuring health-related quality of life among patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

Modeling the Long-Term Outcomes and Costs of HIV Antiretroviral Therapy Using HIV RNA Levels: Application to a Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00048.X

The iterative use of economic evaluation as part of the process of health technology assessment

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1468-1293.2001.00048.X

Selective COX-2 inhibitors and human inflammatory bowel disease

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1468-1293.2001.00048.X

Forum – Taxonomic Stability is Ignorance

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1468-1293.2001.00048.X

Identifiers

DOI

10.1046/J.1468-1293.2001.00048.X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11737376%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference